Condition

Homocystinuria clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Homocystinuria clinical trials that are recruiting, at sites in 15 countries (most in France (2), Qatar (2), United States (2)). By phase: Phase 3 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Homocystinuria clinical trials

StudyPhaseWhereStatusRegistered
Assessing Quality of Life in Patients with Classical Homocystinuria — Zurich Recruiting Aug 16, 2024
Pegtibatinase versus placebo for people 12–65 with classical CBS‑deficient homocystinuria on standard care Phase 3 Phoenix, Arizona and 51 other locations Recruiting Feb 7, 2024
Pegtibatinase for Classical Homocystinuria Phase 1/2 Aurora, Colorado and 11 other locations Recruiting Jan 23, 2018

All recruiting trials (3)

Quick answers

How many Homocystinuria clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 15 countries. The most sites are in France (2 trials), Qatar (2 trials), United States (2 trials), Switzerland (1 trial), Australia (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.